Results 41 to 50 of about 625,280 (217)

Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV

open access: yes, 2010
BACKGROUND: Sensory neuropathy (SN) is common in patients with HIV. Hepatitis C (HCV) coinfection is often cited as an HIV-SN risk factor, but data to support this are lacking.
Djauzi, S   +45 more
core   +4 more sources

Sero-prevalence of syphilis infection among people living with HIV in Sierra Leone: a cross-sectional nationwide hospital-based study

open access: yesBMC Infectious Diseases, 2023
Background Globally, there were an estimated 7.1 million new syphilis infections in 2020, with more than 30% of these new infections reported in African countries such as Sierra Leone.
Darlinda F. Jiba   +10 more
doaj   +1 more source

Low CD4 Counts and History of Sore Throat Predict High SARS-CoV-2 Seropositivity among Human Immunodeficiency Virus-Infected Patients in Mwanza, Tanzania

open access: yesCOVID, 2023
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic.
Helmut A. Nyawale   +9 more
doaj   +1 more source

Clinical progress note: Mumps

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Mumps was a common childhood viral illness before the implementation of the measles, mumps, and rubella (MMR) vaccination in 1967. There was a significant decrease in mumps cases in the postvaccine era; however, there has been an increase in outbreaks in the United States over the past two decades.
Sarah Ludvigsen, Mati Segev
wiley   +1 more source

Screening Indicators of Hepatitis A, Hepatitis B, Hepatitis C and HIV infections in Prisoners

open access: yesViral Hepatitis Journal, 2012
Objective:The study was made in the prisoners who had been under risk for many infectious disease. Our goals to screen Hepatitis A, Hepatitis B, Hepatitis C and HIV indicators with serological methods. And to vaccinate in determined seronegative subjects
Elçin BALCI   +3 more
doaj   +1 more source

Machine Learning Model for Predicting Hepatocellular Carcinoma Development in Patients With Hepatitis B Virus‐Related Cirrhosis Receiving Antiviral Therapy

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Few prediction models have been specifically designed to evaluate the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B and cirrhosis. This study aimed to develop a machine learning‐based prediction model to assess the risk of developing HCC in patients with hepatitis B virus (HBV)‐related cirrhosis undergoing nucleos(
Pao‐Yuan Huang   +4 more
wiley   +1 more source

Coverage, uptake and seropositivity of routine offer of HIV test across the four sites.

open access: yes, 2013
Coverage, uptake and seropositivity of routine offer of HIV test across the four sites.
Gillian Elam (318380)   +9 more
core   +1 more source

Attitudes of Dental Students Towards HIV+ Patients: A Multi‐Center Survey Among Italian Universities

open access: yesEuropean Journal of Dental Education, EarlyView.
ABSTRACT Aims To evaluate the attitudes of Italian dental students towards HIV‐infected patients and explore factors influencing discriminatory behaviour. Methods This observational, multicentric survey analysed responses from dental students across Italian Dental Schools.
Michele Giuliani   +55 more
wiley   +1 more source

[Thrombocytopenia in HIV-1 seropositive hemophiliacs].

open access: yes[Rinsho ketsueki] The Japanese journal of clinical hematology, 1993
When platelet counts were compared in 1986 and 1992 in 117 anti-HIV antibody positive and negative hemophilia patients, a clear decrease was found in the positive group. In 1992 platelet counts < 150 x 10(9) were present in 23.5% of the positive group in contrast to 5.8% of the negative group. Comparing platelet counts with other clinical parameters, a
FUKUTAKE, Katsuyuki   +7 more
openaire   +2 more sources

Bringing Gene Therapy Into Real World Clinical Practice

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy